Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

Federal cuts to funding could “decimate” medical research in the US, delaying cures and costing countless lives.

Sotatercept-csrk reduced the risk of major morbidity and mortality events in adults with WHO Group 1 PAH FC 3 or 4 at high risk of mortality.

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) may reduce the risk of dementia or cognitive impairment.

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

There may be lower risk for HF among patients with low-to-moderate total alcohol consumption, except in women who drink beer, who may have higher risk.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.

A 2-item food security instrument captures similar mortality risk information as instruments with more items among adults in the US.

HealthDay News — The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions ...

Cervical artery dissection incidence increased from 2005 to 2019, with admissions particularly high in older, Black, and Hispanic populations.

The CDC has not only lost nearly a fifth of its workforce, it has also been directed to slash $2.9 billion in contract spending.